New pharmacotherapy for stroke prevention in atrial fibrillation: Update 2010.
Authors : Armaganijan Luciana L; Eikelboom John J; Healey Jeff S JS; Morillo Carlos A CA;
Affiliations : Department of Medicine, Cardiology Division, Arrhythmia Service, McMaster University, HHSC, David Braley CVSRI, Hamilton, Ontario, Canada, L8L 2X2.
Journal : Adv Ther (2009)
Related Links: Pubmed | Publisher website
Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Etiology and Initial Investigations
Authors : Jeff S. Healey, MD, MSc; Ratika Parkash, MD, MSc; Tim Pollak, MD; Teresa Tsang, MD; Paul Dorian, MD;
Affiliations : Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada. Jeff.Healey@phri.ca
Journal : The Canadian Journal of Cardiology (2010)
Related Links: Pubmed | Publisher website
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
Authors : John W. Eikelboom, MBBS; Lars Wallentin, MD; Stuart J. Connolly, MD; Mike Ezekowitz, MD; Jeff S. Healey, MD; Jonas Oldgren, MD; Sean Yang, BComSc; Marco Alings, MD; Scott Kaatz, DO; Stefan H. Hohnloser, MD; Hans-Christoph Diener, MD; Maria Grazia Franzosi, PhD; Kurt Huber, MD; Paul Reilly, MD; Jeanne Varrone, MD;
Affiliations : Correspondence to John Eikelboom, MBBS, Population Health Research Institute, 237 Barton St E, Hamilton, Ontario, Canada L8L 2X2. E-mail eikelbj@mcmaster.ca
Journal : Circulation (2011)
Related Links: Pubmed | Publisher website
Irbesartan in Patients with Atrial Fibrillation
Authors : Yusuf S; Healey JS; Pogue J; Chrolavicius S; Flather M; Hart RG; Hohnloser SH; Joyner CD; Pfeffer MA;
Affiliations : Dr. Yusuf at the Population Health Research Institute, David Braley Cardiac, Vascular and Stroke Research Institute, Hamilton Health Sciences and McMaster University, 237 Barton St. East, Hamilton, ON L8L 2X2, Canada, or at yusufs@mcmaster.ca.
Journal : The New England Journal of medicine (2011)
Related Links: Pubmed | Publisher website
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
Authors : John W. Eikelboom, MBBS; Lars Wallentin, MD; Stuart J. Connolly, MD; Mike Ezekowitz, MD; Jeff S. Healey, MD; Jonas Oldgren, MD; Sean Yang, BComSc; Marco Alings, MD; Scott Kaatz, DO; Stefan H. Hohnloser, MD; Hans-Christoph Diener, MD; Maria Grazia Franzosi, PhD; Kurt Huber, MD; Paul Reilly, MD; Jeanne Varrone, MD;
Affiliations : Correspondence to John Eikelboom, MBBS, Population Health Research Institute, 237 Barton St E, Hamilton, Ontario, Canada L8L 2X2. E-mail eikelbj@mcmaster.ca
Journal : N/A (2011)
Related Links: Pubmed | Publisher website
Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial.
Authors : Eikelboom JW; Wallentin L; Connolly SJ; Ezekowitz M; Healey JS; Oldgren J; Yang S; Alings M; Kaatz S; Hohnloser SH; Diener HC; Franzosi MG; Huber K; Reilly P; Varrone J;
Affiliations : Correspondence to John Eikelboom, MBBS, Population Health Research Institute, 237 Barton St E, Hamilton, Ontario, Canada L8L 2X2. E-mail eikelbj@mcmaster.ca
Journal : Circulation (2011)
Related Links: Pubmed | Publisher website
Display Ads on JAFIB to reach Users world wide...
Suggest an Event to get good mileage from Users World wide...